PL2241554T3 - Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie - Google Patents

Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie

Info

Publication number
PL2241554T3
PL2241554T3 PL10290166T PL10290166T PL2241554T3 PL 2241554 T3 PL2241554 T3 PL 2241554T3 PL 10290166 T PL10290166 T PL 10290166T PL 10290166 T PL10290166 T PL 10290166T PL 2241554 T3 PL2241554 T3 PL 2241554T3
Authority
PL
Poland
Prior art keywords
ivabradine
synthesis
pharmaceutically acceptable
acid addition
addition salts
Prior art date
Application number
PL10290166T
Other languages
English (en)
Inventor
Jean-Louis Peglion
AIMéE DESSINGES
Bernard Serkiz
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40984744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2241554(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2241554T3 publication Critical patent/PL2241554T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL10290166T 2009-03-31 2010-03-30 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie PL2241554T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901555A FR2943667B1 (fr) 2009-03-31 2009-03-31 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
EP10290166A EP2241554B1 (fr) 2009-03-31 2010-03-30 Nouveau procédé de synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
PL2241554T3 true PL2241554T3 (pl) 2012-01-31

Family

ID=40984744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10290166T PL2241554T3 (pl) 2009-03-31 2010-03-30 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie

Country Status (36)

Country Link
US (1) US8101747B2 (pl)
EP (1) EP2241554B1 (pl)
JP (1) JP5107382B2 (pl)
KR (1) KR101166630B1 (pl)
CN (2) CN102603634B (pl)
AR (1) AR075977A1 (pl)
AT (1) ATE523494T1 (pl)
AU (1) AU2010201058B2 (pl)
BR (1) BRPI1000735A2 (pl)
CA (1) CA2697562C (pl)
CL (1) CL2010000254A1 (pl)
CY (1) CY1112136T1 (pl)
DK (1) DK2241554T3 (pl)
EA (1) EA016335B1 (pl)
ES (1) ES2373369T3 (pl)
FR (1) FR2943667B1 (pl)
GE (1) GEP20125460B (pl)
HR (1) HRP20110915T1 (pl)
JO (1) JO2782B1 (pl)
MA (1) MA31745B1 (pl)
ME (1) ME00987B (pl)
MX (1) MX2010003184A (pl)
MY (1) MY145611A (pl)
NZ (1) NZ584309A (pl)
PE (1) PE20100714A1 (pl)
PL (1) PL2241554T3 (pl)
PT (1) PT2241554E (pl)
RS (1) RS51962B (pl)
SA (1) SA110310240B1 (pl)
SG (1) SG165254A1 (pl)
SI (1) SI2241554T1 (pl)
TW (1) TWI419879B (pl)
UA (1) UA102232C2 (pl)
UY (1) UY32500A (pl)
WO (1) WO2010112704A1 (pl)
ZA (1) ZA201002121B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101478855B1 (ko) * 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
CN103724266B (zh) * 2014-01-20 2018-12-04 山东诚创医药技术开发有限公司 去甲伊伐布雷定盐及其制备方法和应用
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN108530359A (zh) * 2017-03-01 2018-09-14 浙江京新药业股份有限公司 一种伊伐布雷定杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140049A (en) * 1965-04-02 1969-01-15 Alphachimie S A N-substituted tetrahydrobenzazepines
US3743731A (en) * 1971-03-16 1973-07-03 Schering Corp Substituted benzazepines for producing skeletal muscle relaxation
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2097383B1 (en) * 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101284813B (zh) * 2007-04-12 2012-08-15 上海优拓医药科技有限公司 伊伐布雷定的制备方法
KR101478855B1 (ko) 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법

Also Published As

Publication number Publication date
SI2241554T1 (sl) 2012-01-31
CY1112136T1 (el) 2015-11-04
EP2241554B1 (fr) 2011-09-07
CA2697562C (fr) 2012-05-15
PT2241554E (pt) 2011-10-17
TWI419879B (zh) 2013-12-21
HK1169827A1 (en) 2013-02-08
JP5107382B2 (ja) 2012-12-26
CN102603634A (zh) 2012-07-25
JP2010241809A (ja) 2010-10-28
EA201000397A1 (ru) 2010-12-30
CL2010000254A1 (es) 2011-04-25
CN101851205B (zh) 2013-02-13
NZ584309A (en) 2010-11-26
KR20100109526A (ko) 2010-10-08
SG165254A1 (en) 2010-10-28
UA102232C2 (uk) 2013-06-25
US20100249397A1 (en) 2010-09-30
UY32500A (es) 2010-09-30
RS51962B (sr) 2012-02-29
MX2010003184A (es) 2010-10-05
CN102603634B (zh) 2014-04-16
HK1148748A1 (en) 2011-09-16
TW201040144A (en) 2010-11-16
PE20100714A1 (es) 2010-10-30
MY145611A (en) 2012-03-05
US8101747B2 (en) 2012-01-24
BRPI1000735A2 (pt) 2011-04-19
HRP20110915T1 (hr) 2011-12-31
FR2943667A1 (fr) 2010-10-01
ATE523494T1 (de) 2011-09-15
AU2010201058B2 (en) 2015-02-05
FR2943667B1 (fr) 2011-05-06
CA2697562A1 (fr) 2010-09-30
WO2010112704A1 (fr) 2010-10-07
JO2782B1 (en) 2014-03-15
KR101166630B1 (ko) 2012-07-19
AR075977A1 (es) 2011-05-11
GEP20125460B (en) 2012-03-26
EA016335B1 (ru) 2012-04-30
ZA201002121B (en) 2010-11-24
MA31745B1 (fr) 2010-10-01
ME00987B (me) 2012-06-20
ES2373369T3 (es) 2012-02-02
AU2010201058A1 (en) 2010-10-14
EP2241554A1 (fr) 2010-10-20
CN101851205A (zh) 2010-10-06
SA110310240B1 (ar) 2013-07-28
DK2241554T3 (da) 2011-12-12

Similar Documents

Publication Publication Date Title
IL238337A (en) A process for preparing pharmaceutical active compounds
ZA201105172B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IL207487A0 (en) Process for the regioselective synthesis of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
IL220211A0 (en) Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives
PL2241553T3 (pl) Sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie
HRP20140928T1 (en) Process for the synthesis of the 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, and its application to the synthesis of ivabradine as well as its addition salts with a pharmaceutically acceptable acid
SG175066A1 (en) 6'-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
ZA201200821B (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
ZA201201329B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ZA201105709B (en) Process for the synthesis of cleistanthin
PT2241554E (pt) Novo processo de síntese da ivabradina e dos seus sais de adição a um ácido aceitável do ponto de vista farmacêutico
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers
PT2607354E (pt) Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico
PT2419407E (pt) Processo melhorado para a preparação de fluvastatina e dos seus sais
PL2398779T3 (pl) Nowy sposób wytwarzania kwasu nitroorotowego
ZA201000159B (en) Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
HUP0900795D0 (en) Process for producing of pharmaceutically active agent
ZA200905507B (en) Improved process for the preparation of phenethylamine derivatives
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HUP0900209A2 (en) Process for the preparation of cyclohexanol derivatives